Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesImpact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico
Rheumatology, 08/31/09
Uribe AG et al. – Texan patients had more severe disease than Mexican patients.
Methods- Mexican and Texan patients participating in separate longitudinal outcome studies were evaluated
- 70 Mexican patients were matched with 1 or 2 Texan patients
- Mexican patients had less systemic SLE manifestations
Graciela S. Alarcón, 08/31/09
| It is not clear what the reasons for the differences btween the Mexican and Texan patients are. We could not confirm that the main reasons were socioeconomic although Mexians who choose to emigrate to the US are overall of a lower socioeconomic status than those who do not. Nevertheless our data should alert physicians managing patients of Hispanic origin in the US of their potential for having a severe disease and treat them accordingly; this will prevent undesirable outcomes in this minority population group. |
Today in Systemic Lupus (SLE)...keeping you current
Receive free subspecialty "5-minute updates" via email
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial
Annals of Rheumatic Diseases, 11/10/09
Influence of race/ethnicity on response to lupus nephritis treatment: The ALMS study
Rheumatology, 11/24/09
Sponsor
Article Search
Sponsor